Melqart Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Melqart Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-713,000	Closed	-$17M	–	162
2021 Q1	$17M	Buy	+713,000	New	+$13.3M	0.77%	30

Melqart Asset Management's GNMK Position: Q2 2021 in Review

Melqart Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 713,000 shares — an estimated $17M sold.

Melqart Asset Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $17M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Melqart Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Melqart Asset Management sold 713,000 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $17M.
Melqart Asset Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Melqart Asset Management's GenMark Diagnostics, Inc position peaked at $17M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Melqart Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.